1. Home
  2. FOXX vs PLUR Comparison

FOXX vs PLUR Comparison

Compare FOXX & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

N/A

Current Price

$2.57

Market Cap

17.3M

Sector

N/A

ML Signal

N/A

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$0.97

Market Cap

18.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FOXX
PLUR
Founded
2017
2001
Country
United States
Israel
Employees
25
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
18.5M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
FOXX
PLUR
Price
$2.57
$0.97
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $12.00
AVG Volume (30 Days)
4.9K
★ 16.6K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.46
EPS
★ N/A
N/A
Revenue
N/A
★ $1,016,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.71
$0.98
52 Week High
$7.90
$4.87

Technical Indicators

Market Signals
Indicator
FOXX
PLUR
Relative Strength Index (RSI) 42.74 29.10
Support Level $2.29 N/A
Resistance Level $4.84 $1.85
Average True Range (ATR) 0.20 0.13
MACD -0.01 -0.00
Stochastic Oscillator 34.84 9.76

Price Performance

Historical Comparison
FOXX
PLUR

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: